Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biopharma M&A Volume, Value Bounced Back Significantly In Q4

Executive Summary

Acquisition activity in the biopharmaceutical sector saw a strong uptick in deal value and an exponential increase in total deal value during the fourth quarter, according to data from Evaluate.

You may also be interested in...



Q1 2024 Posts Big M&A Total Led By Novo Holdings’ Catalent Takeout

The $16.5bn deal, intended to increase Novo Nordisk’s production of semaglutide-containing products, led a $36bn-plus quarter for M&A transactions, according to Evaluate.

Going Into 2024, PWC Predicts Healthy Atmosphere For M&A

Quick accretion may be more important to acquirers than revenue growth potential, the firm’s annual outlook states. A variety of pressures will increase emphasis on strategic deal-making.

AstraZeneca's Gracell Acquisition Injects New Excitement For Cell Therapy In China

The UK drug maker’s latest deal marks the largest China biotech M&A deal to date, amid the lingering doom and gloom surrounding the fast emerging but cash-constrained sector.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC149605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel